Effectiveness of intravenous ketamine in mood disorder patients with a history of neurostimulation.
Nelson B RodriguesAshley SiegelOrly LipsitzDanielle S ChaHartej GillFlora NasriKevin SimonsonMargarita ShekotikhinaYena LeeMehala SubramaniapillaiKevin KratiukKangguang LinRoger HoRodrigo B MansurRoger S McIntyreJoshua D RosenblatPublished in: CNS spectrums (2020)
IV ketamine was effective in reducing symptoms of depression, SI, anxiety, and anhedonia in both cohorts in this large, well-characterized community-based sample of adults with TRD.